Mast cell and eosinophil surface receptors as targets for anti‐allergic therapy
暂无分享,去创建一个
Francesca Levi-Schaffer | F. Levi-Schaffer | Roopesh Singh Gangwar | Nadine Landolina | Ludovica Arpinati | N. Landolina | R. S. Gangwar | L. Arpinati | F. Levi‐Schaffer | Nadine Landolina
[1] Markku Miettinen,et al. KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation , 2005, Applied immunohistochemistry & molecular morphology : AIMM.
[2] S. Durham,et al. Increased expression of high affinity ige (FcεRI) receptor-α chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma , 1998 .
[3] Q. Hamid,et al. Increased IL-33 expression by epithelial cells in bronchial asthma. , 2010, The Journal of allergy and clinical immunology.
[4] P. Foster,et al. Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease , 2012, Mucosal Immunology.
[5] L. Kay,et al. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation , 2006, British journal of pharmacology.
[6] Jianxun Lei,et al. Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation , 2016, Haematologica.
[7] F. Borrego,et al. The Biology and Disease Relevance of CD300a, an Inhibitory Receptor for Phosphatidylserine and Phosphatidylethanolamine , 2015, The Journal of Immunology.
[8] C. Ozdemir. Monoclonal antibodies in allergy; updated applications and promising trials. , 2009, Recent patents on inflammation & allergy drug discovery.
[9] I. Kariv,et al. CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity. , 2007, Bioorganic & medicinal chemistry letters.
[10] Zaheer Ul-Haq,et al. Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box. , 2016, Cytokine & growth factor reviews.
[11] I. Bachelet,et al. Eosinophil major basic protein activates human cord blood mast cells primed with fibroblast membranes by integrin‐β1 , 2013, Allergy.
[12] M. Lamers,et al. Human MAFA has alternatively spliced variants. , 1998, Biochimica et biophysica acta.
[13] F. Levi-Schaffer,et al. Human Mast Cell Activation by Staphylococcus aureus: Interleukin-8 and Tumor Necrosis Factor Alpha Release and the Role of Toll-Like Receptor 2 and CD48 Molecules , 2008, Infection and Immunity.
[14] Max E Valentinuzzi,et al. SAFETY AND EFFICACY , 2010 .
[15] R. Thurmond. The histamine H4 receptor: from orphan to the clinic , 2015, Front. Pharmacol..
[16] N. Flamand,et al. CCL26/eotaxin‐3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin‐1 and CCL24/eotaxin‐2 , 2013, Journal of leukocyte biology.
[17] I. Bachelet,et al. The Inhibitory Receptor IRp60 (CD300a) Is Expressed and Functional on Human Mast Cells1 , 2005, The Journal of Immunology.
[18] J. J. Walsh,et al. Mast cell stabilisers. , 2016, European journal of pharmacology.
[19] J. Gern. Virus/Allergen Interaction in Asthma Exacerbation. , 2015, Annals of the American Thoracic Society.
[20] L. Boulet,et al. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. , 2008, American journal of respiratory and critical care medicine.
[21] H. Subramanian,et al. Mas-related Gene X2 (MrgX2) Is a Novel G Protein-coupled Receptor for the Antimicrobial Peptide LL-37 in Human Mast Cells , 2011, The Journal of Biological Chemistry.
[22] É. Vivier,et al. Immunoreceptor tyrosine‐based inhibition motifs: a quest in the past and future , 2008, Immunological reviews.
[23] M. Rothenberg,et al. Humanized Anti-IL-5 Antibody Therapy , 2016, Cell.
[24] M. Joseph,et al. Expression and functions of the high‐affinity IgE receptor on human platelets and megakaryocyte precursors , 1997, European journal of immunology.
[25] R. Proia,et al. Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages , 2008, Circulation research.
[26] J. Ring,et al. Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab. , 2016, Acta dermato-venereologica.
[27] U. Sivaprasad,et al. Th2 Cytokines and Atopic Dermatitis. , 2011, Journal of clinical & cellular immunology.
[28] K. Dyer,et al. Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.
[29] Qutayba Hamid,et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. , 2003, The Journal of clinical investigation.
[30] D. Kemeny,et al. Inhibition of Th1- and Th2-Mediated Airway Inflammation by the Sphingosine 1-Phosphate Receptor Agonist FTY720 , 2003, The Journal of Immunology.
[31] H. Stark,et al. Cherry-picked ligands at histamine receptor subtypes , 2016, Neuropharmacology.
[32] K. Aozasa,et al. SIRPα/CD172a Regulates Eosinophil Homeostasis , 2011, The Journal of Immunology.
[33] M. Neurath,et al. Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma. , 2001, The Journal of allergy and clinical immunology.
[34] E. A. Schwantes,et al. IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation , 2012, Clinical and Molecular Allergy.
[35] J. Lee,et al. Clinical Trial of Human Umbilical Cord Blood‐Derived Stem Cells for the Treatment of Moderate‐to‐Severe Atopic Dermatitis: Phase I/IIa Studies , 2017, Stem cells.
[36] Trevor T. Hansel,et al. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases , 2007, Nature Reviews Drug Discovery.
[37] Y. Jang,et al. Detection of respiratory viruses in adult patients with perennial allergic rhinitis , 2013, Annals of Allergy, Asthma & Immunology.
[38] A. Hershko,et al. CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis , 2013, Mucosal Immunology.
[39] I. Bachelet,et al. Interacting mast cells and eosinophils acquire an enhanced activation state in vitro , 2013, Allergy.
[40] Santa Jeremy Ono,et al. Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade. , 2009, International Immunology.
[41] K. Mackie,et al. An Introduction to the Endogenous Cannabinoid System , 2016, Biological Psychiatry.
[42] T. Kamijo,et al. STI571 inhibits growth and adhesion of human mast cells in culture , 2003, Journal of leukocyte biology.
[43] Cerys Docx,et al. Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases. , 2013, Bioorganic & medicinal chemistry.
[44] G. Nilsson,et al. Effects of interleukin (IL)‐13 on immediate‐early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL‐4 , 1995, European journal of immunology.
[45] Cgcgtgctaatggtggaaa,et al. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis , and exogenous IL-33 promotes eosinophilic esophagitis development in mice , 2015 .
[46] R. Wilhelm,et al. CCR3 antagonists: a survey of the patent literature , 2009, Expert opinion on therapeutic patents.
[47] S. Escher,et al. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases , 2004, Allergy.
[48] S. Milstien,et al. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. , 2015, The Journal of allergy and clinical immunology.
[49] P. Mathew,et al. Functional role of human NK cell receptor 2B4 (CD244) isoforms , 2009, European journal of immunology.
[50] D. Kendall,et al. The endogenous cannabinoid anandamide increases human airway epithelial cell permeability through an arachidonic acid metabolite. , 2016, Pharmacological research.
[51] G. O'neill,et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. , 2001, The Journal of allergy and clinical immunology.
[52] Hiroki Nakanishi,et al. Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid* , 2012, The Journal of Biological Chemistry.
[53] 松岡 俊行. Prostaglandin D2 as a mediator of allergic asthmaに関する研究 , 2000 .
[54] Zahra Ahmadi,et al. An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis , 2016, Inflammation.
[55] Hong-Yang Wang,et al. Signal regulatory protein α negatively regulates mast‐cell activation following FcεRI aggregation , 2013, European journal of immunology.
[56] Calman Prussin,et al. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[57] G. O'neill,et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2 , 2002, British journal of pharmacology.
[58] T. Abe,et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. , 2012, Immunity.
[59] D. Dombrowicz,et al. Human Eosinophils and Human High Affinity IgE Receptor Transgenic Mouse Eosinophils Express Low Levels of High Affinity IgE Receptor, but Release IL-10 upon Receptor Activation , 2001, The Journal of Immunology.
[60] F. Levi-Schaffer,et al. Mast cells and eosinophils: the two key effector cells in allergic inflammation , 2009, Inflammation Research.
[61] L. Boulet,et al. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo‐controlled clinical trial , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[62] T. Igawa,et al. Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation , 2016, Immunological reviews.
[63] H. Aguilar,et al. IREM‐1 is a novel inhibitory receptor expressed by myeloid cells , 2004, European journal of immunology.
[64] D. Stanworth,et al. Inhibition of binding of rat IgE to rat mast cells by synthetic IgE peptides , 1987, European journal of immunology.
[65] K. Sugamura,et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. , 1999, Journal of immunology.
[66] S. Hoffjan,et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life , 2002, European Respiratory Journal.
[67] A. Kurosky,et al. FcγRIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma , 2010, PloS one.
[68] I. Bachelet,et al. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. , 2006, The Journal of allergy and clinical immunology.
[69] S. Galli,et al. Toward precision medicine and health: Opportunities and challenges in allergic diseases. , 2016, The Journal of allergy and clinical immunology.
[70] I. Bachelet,et al. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. , 2006, Blood.
[71] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[72] S. Liour,et al. Treating IgE‐mediated diseases via targeting IgE‐expressing B cells using an anti‐CεmX antibody , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[73] T. Sugiura,et al. Chemotaxis of Human Peripheral Blood Eosinophils to 2-Arachidonoylglycerol: Comparison with Other Eosinophil Chemoattractants , 2006, International Archives of Allergy and Immunology.
[74] K. Hashimoto,et al. CD300 antigen like family member G: A novel Ig receptor like protein exclusively expressed on capillary endothelium. , 2006, Biochemical and biophysical research communications.
[75] C. Adra,et al. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. , 2005, The Biochemical journal.
[76] L. Reber,et al. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. , 2006, European journal of pharmacology.
[77] M. Kubin,et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.
[78] A. Ullrich,et al. Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.
[79] J. Denburg,et al. Human mast cell and basophil/eosinophil progenitors. , 2015, Methods in molecular biology.
[80] A. Sharpe,et al. Roles of CD48 in regulating immunity and tolerance. , 2016, Clinical immunology.
[81] M. Číž,et al. Histamine Receptors and Inflammatory Cells , 2013 .
[82] Y. Kitamura,et al. Mutual phenotypic changes between connective tissue type and mucosal mast cells. , 1987, International archives of allergy and applied immunology.
[83] J. Phillips,et al. The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function1 , 2005, The Journal of Immunology.
[84] H. Nakanishi,et al. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[85] F. Levi-Schaffer,et al. The inhibitory receptor CD300a is up‐regulated by hypoxia and GM‐CSF in human peripheral blood eosinophils , 2013, Allergy.
[86] R. Eliashar,et al. Mast cell stabilizing properties of antihistamines. , 2009, The Journal of investigative dermatology.
[87] R. Blakely,et al. A dialogue between the immune system and brain, spoken in the language of serotonin. , 2013, ACS chemical neuroscience.
[88] J. Kinet,et al. A second amplifier function for the allergy-associated Fc(epsilon)RI-beta subunit. , 2000, Immunity.
[89] O. Mandelboim,et al. 2B4 (CD244) Is Expressed and Functional on Human Eosinophils1 , 2005, The Journal of Immunology.
[90] P. Foster,et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma , 2012, Thorax.
[91] L. Petecchia,et al. Pharmacological Modulation of the Bradykinin-Induced Differentiation of Human Lung Fibroblasts: Effects of Budesonide and Formoterol , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.
[92] G. Sturm,et al. 11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils* , 2004, Journal of Biological Chemistry.
[93] M. Das,et al. Macrophages in food allergy: an enigma. , 2013, Molecular immunology.
[94] Gordon D. Brown,et al. Inhibitory C-type lectin receptors in myeloid cells , 2011, Immunology letters.
[95] P. Kuna,et al. Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma , 2016, BMJ Open.
[96] R. Paus,et al. Endocannabinoids limit excessive mast cell maturation and activation in human skin. , 2012, The Journal of allergy and clinical immunology.
[97] D. Metcalfe,et al. Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation. , 2007, Inflammation & allergy drug targets.
[98] C. Bruijnzeel-Koomen,et al. Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. , 1998, American journal of respiratory cell and molecular biology.
[99] P. O'Byrne,et al. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. , 2010, The Journal of allergy and clinical immunology.
[100] R. Mariuzza,et al. Molecular Basis of the Dual Functions of 2B4 (CD244)1 , 2008, The Journal of Immunology.
[101] M. Rothenberg,et al. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. , 2008, Blood.
[102] F. Di Virgilio,et al. Activation of human eosinophils via P2 receptors: novel findings and future perspectives , 2006, Journal of leukocyte biology.
[103] Effect of nilotinib on airway remodeling in a murine model of chronic asthma , 2014, Experimental lung research.
[104] N. Birmingham,et al. CCR3 and CXCR3 as drug targets for allergy: principles and potential. , 2003, Current drug targets. Inflammation and allergy.
[105] R. Biassoni,et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells , 1999, European journal of immunology.
[106] J. Pollard,et al. Postnatal mammary gland development requires macrophages and eosinophils. , 2000, Development.
[107] K. Akashi,et al. Identification of eosinophil lineage–committed progenitors in the murine bone marrow , 2005, The Journal of experimental medicine.
[108] T. Hansel,et al. Antagonists of the prostaglandin D2 receptor CRTH2. , 2008, Drug news & perspectives.
[109] G. Hardiman,et al. CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[110] M. Idzko,et al. Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. , 2013, American journal of respiratory and critical care medicine.
[111] W. Fridman,et al. Negative regulation of mast cell proliferation by FcgammaRIIB. , 2002, Molecular immunology.
[112] J. Coligan,et al. CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection. , 2011, Blood.
[113] C. Galeone,et al. Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases , 2015, Journal of asthma and allergy.
[114] R. Leatherbarrow,et al. Development of small molecules to target the IgE:FcεRI protein-protein interaction in allergies. , 2013, Future medicinal chemistry.
[115] F. Poccia,et al. Sphingosine 1‐Phosphate Interferes on the Differentiation of Human Monocytes into Competent Dendritic Cells , 2007, Scandinavian journal of immunology.
[116] J. Kinet,et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. , 1996, Journal of immunology.
[117] M. Toth,et al. 5-Hydroxytryptamine Induces Mast Cell Adhesion and Migration1 , 2006, The Journal of Immunology.
[118] S. Waggoner,et al. Evolving role of 2B4/CD244 in T and NK cell responses during virus infection , 2012, Front. Immun..
[119] C. Wong,et al. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. , 2010, American journal of respiratory cell and molecular biology.
[120] Lars Karlsson,et al. A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties , 2004, Journal of Pharmacology and Experimental Therapeutics.
[121] D. Yuan. Comment on “Molecular Basis of the Dual Functions of 2B4 (CD244)” , 2008, The Journal of Immunology.
[122] C. Cetrulo,et al. Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway , 2006, Molecular Pharmacology.
[123] J. Tavernier,et al. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[124] J. A. Jablonowski,et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. , 2003, Journal of medicinal chemistry.
[125] M. Heidtman,et al. Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)–mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1) , 1997, The Journal of experimental medicine.
[126] R. Jackson,et al. IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants. , 2014, Cytokine & growth factor reviews.
[127] J. Tavernier,et al. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. , 1993, The Journal of biological chemistry.
[128] M. Whittaker,et al. Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis. , 2012, Journal of medicinal chemistry.
[129] P. Bradding,et al. New Developments in Mast Cell Biology: Clinical Implications. , 2016, Chest.
[130] P. Calverley,et al. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD , 2016, European Respiratory Journal.
[131] J. N. Sharma. Basic and clinical aspects of bradykinin receptor antagonists. , 2014, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[132] M. McNerney,et al. 2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells , 2004, The Journal of experimental medicine.
[133] Zhou-Feng Chen,et al. Itch signaling in the nervous system. , 2011, Physiology.
[134] L Meyaard,et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. , 1997, Immunity.
[135] W. Hubbard,et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. , 2008, The Journal of allergy and clinical immunology.
[136] P. Thompson,et al. Expression of kinin receptors on eosinophils: comparison of asthmatic patients and healthy subjects , 2009, Journal of leukocyte biology.
[137] I. Adcock,et al. Kinase Targets and Inhibitors for the Treatment of Airway Inflammatory Diseases , 2012, BioDrugs.
[138] P. Pacher,et al. The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.
[139] R. Ahrens,et al. Loss of IL‐4Rα–mediated PI3K signaling accelerates the progression of IgE/mast cell–mediated reactions , 2015, Immunity, inflammation and disease.
[140] C. Brightling,et al. Mast cells express IL‐13Rα1: IL‐13 promotes human lung mast cell proliferation and FcɛRI expression , 2006, Allergy.
[141] B. Hudson,et al. The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35 , 2014, Molecular Pharmacology.
[142] Y. Persidsky,et al. Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation , 2013, Journal of Neuroimmune Pharmacology.
[143] J. Lindsten,et al. The Nobel Prize in Physiology or Medicine , 2001 .
[144] D. Slipetz,et al. Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist , 2011, Molecular Pharmacology.
[145] F. Levi-Schaffer,et al. Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release1 , 2002, The Journal of Immunology.
[146] S. Asadi,et al. Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin , 2012, Journal of Neuroinflammation.
[147] M. Waldhoer,et al. CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases , 2010, Pharmacology.
[148] N. Bovin,et al. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and ‐independent mechanisms , 2003, European journal of immunology.
[149] K. Akashi,et al. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor , 2009, The Journal of experimental medicine.
[150] M. Rothenberg,et al. The Pan-B Cell Marker CD22 Is Expressed on Gastrointestinal Eosinophils and Negatively Regulates Tissue Eosinophilia , 2012, The Journal of Immunology.
[151] J. Westwick,et al. The function of CCR3 on mouse bone marrow‐derived mast cells in vitro , 2010, Immunology.
[152] P. Parham,et al. Coordinated Regulation of NK Receptor Expression in the Maturing Human Immune System , 2014, The Journal of Immunology.
[153] R. Thurmond,et al. The Histamine H 4 Receptor Antagonist , JNJ 39758979 , Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects , 2014 .
[154] P. Weller,et al. Eosinophil crystalloid granules: structure, function, and beyond , 2012, Journal of leukocyte biology.
[155] A. West,et al. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). , 2000, Immunity.
[156] C. Brightling,et al. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease , 2016, Therapeutic advances in chronic disease.
[157] F. Levi-Schaffer,et al. Novel Identified Receptors on Mast Cells , 2012, Front. Immun..
[158] Q. Hamid,et al. The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up-Regulated by Th2 Cytokines in CD34+ Progenitor Cells1 , 2003, The Journal of Immunology.
[159] T. Tsubata,et al. High-affinity ligands of Siglec receptors and their therapeutic potentials. , 2011, Current medicinal chemistry.
[160] M. Lindsay,et al. Pharmacology of the eosinophil. , 1999, Pharmacological reviews.
[161] Na‐Ra Han,et al. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. , 2014, The Journal of investigative dermatology.
[162] B. Czarnetzki,et al. Expression of the high affinity IgE-receptor on human Langerhans' cells. Elucidating the role of epidermal IgE in atopic eczema. , 1992, Acta dermato-venereologica.
[163] Jon D. Wright,et al. Two potential therapeutic antibodies bind to a peptide segment of membrane-bound IgE in different conformations , 2014, Nature Communications.
[164] P. Ogbogu,et al. Hypereosinophilic Syndrome , 2015, Clinical Reviews in Allergy & Immunology.
[165] T. K. van den Berg,et al. Signal Regulatory Proteins in the Immune System , 2005, The Journal of Immunology.
[166] Q. Hamid,et al. Effects of Prostaglandin D2, 15-Deoxy-Δ12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.
[167] L. Schwartz,et al. Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[168] C. Bandeira‐Melo,et al. Co‐operative signalling through DP1 and DP2 prostanoid receptors is required to enhance leukotriene C4 synthesis induced by prostaglandin D2 in eosinophils , 2011, British journal of pharmacology.
[169] J. Phillips,et al. Identification of tyrosine residues crucial for CD200R‐mediated inhibition of mast cell activation , 2006, Journal of leukocyte biology.
[170] I. Pavord,et al. A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[171] F. Levi-Schaffer,et al. Expressions and inhibitory functions of CD300a receptors on purified human basophils , 2012, Experimental dermatology.
[172] A. Martini,et al. The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production , 2010, PloS one.
[173] R. Hernández-Pando,et al. Mast Cell Activation by Mycobacterium tuberculosis: Mediator Release and Role of CD48 1 , 2003, The Journal of Immunology.
[174] H. Kita,et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. , 2014, The Journal of allergy and clinical immunology.
[175] J. Kinet,et al. A Second Amplifier Function for the Allergy-Associated FcεRI-β Subunit , 2000 .
[176] A. Licari,et al. From IgE to clinical trials of allergic rhinitis , 2015, Expert review of clinical immunology.
[177] R. Mechoulam,et al. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .
[178] D. Vignali,et al. Inhibitory receptors as targets for cancer immunotherapy , 2015, European journal of immunology.
[179] Eugene Y. Kim,et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.
[180] L. Petecchia,et al. Bradykinin B2 receptor expression in the bronchial mucosa of allergic asthmatics: the role of NF‐kB , 2016, Clinical and Experimental Allergy.
[181] A. Klion,et al. Biologic therapies targeting eosinophils: current status and future prospects. , 2015, The journal of allergy and clinical immunology. In practice.
[182] M. Caruso,et al. Bradykinin differentiates human lung fibroblasts to a myofibroblast phenotype via the B2 receptor. , 2005, The Journal of allergy and clinical immunology.
[183] W. Janssen,et al. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. , 2015, The Journal of allergy and clinical immunology.
[184] E. Fröhlich,et al. EP4 receptor stimulation down-regulates human eosinophil function , 2011, Cellular and Molecular Life Sciences.
[185] D. Jackson,et al. Absence of Platelet Endothelial Cell Adhesion Molecule-1 (CD31) Leads to Increased Severity of Local and Systemic IgE-Mediated Anaphylaxis and Modulation of Mast Cell Activation1 , 2002, The Journal of Immunology.
[186] H. Na,et al. IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils. , 2012, Cytokine.
[187] K. Matsumoto,et al. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells , 2006, Allergy.
[188] S. McCormick,et al. Commentary: IL-4 and IL-13 receptors and signaling. , 2015, Cytokine.
[189] R. El Bekay,et al. Neutrophils as a Novel Source of Eosinophil Cationic Protein in IgE-Mediated Processes1 , 2007, The Journal of Immunology.
[190] E. Kostenis,et al. Emerging roles of DP and CRTH2 in allergic inflammation. , 2006, Trends in molecular medicine.
[191] G. Boeckxstaens. Mast cells and inflammatory bowel disease. , 2015, Current opinion in pharmacology.
[192] Stephen M. Canham,et al. Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion , 2013, Nature chemical biology.
[193] A. Çilli,et al. Omalizumab treatment in asthma-COPD overlap syndrome , 2016, The Journal of asthma : official journal of the Association for the Care of Asthma.
[194] S. Nabavi,et al. Ligands for cannabinoid receptors, promising anticancer agents. , 2016, Life sciences.
[195] P. Crocker,et al. Evolution of CD33‐related siglecs: regulating host immune functions and escaping pathogen exploitation? , 2011, Immunology.
[196] Bin Chen,et al. The Histamine H4 Receptor Antagonist, JNJ 39758979, Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[197] S. Woo,et al. IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[198] M. Amiot,et al. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. , 1991, Journal of immunology.
[199] M. Brann,et al. Characterization of the Mas‐related gene family: structural and functional conservation of human and rhesus MrgX receptors , 2006, British journal of pharmacology.
[200] F. Di Virgilio,et al. 5-Hydroxytryptamine Modulates Migration, Cytokine and Chemokine Release and T-Cell Priming Capacity of Dendritic Cells In Vitro and In Vivo , 2009, PLoS ONE.
[201] J. Coligan,et al. CD300f associates with IL-4 receptor α and amplifies IL-4–induced immune cell responses , 2015, Proceedings of the National Academy of Sciences.
[202] W. Fridman,et al. Negative regulation of mast cell proliferation by FcγRIIB , 2002 .
[203] B. Hargadon,et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. , 2012, The Journal of allergy and clinical immunology.
[204] Q. Hamid,et al. Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[205] H. Kita,et al. IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs , 2012, The Journal of Immunology.
[206] Eric O Long,et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). , 2005, Blood.
[207] E. Israel,et al. Update on reslizumab for eosinophilic asthma , 2015, Expert opinion on biological therapy.
[208] C. Chen,et al. Mast cell regulation via paired immunoglobulin-like receptor PIR-B , 2002, Immunologic research.
[209] S. Spiegel,et al. The role of sphingosine-1-phosphate and its receptors in asthma. , 2008, Drug news & perspectives.
[210] K. Sugamura,et al. CRTH2, an orphan receptor of T‐helper‐2‐cells, is expressed on basophils and eosinophils and responds to mast cell‐derived factor(s) , 1999, FEBS letters.
[211] R. Zeldin,et al. Treatment of chronic autoimmune urticaria with omalizumab. , 2008, The Journal of allergy and clinical immunology.
[212] V. Natarajan,et al. [The Nobel Prize in physiology or medicine]. , 1998, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[213] R. Kiss,et al. Histamine H4 receptor ligands and their potential therapeutic applications: an update , 2012, Expert opinion on therapeutic patents.
[214] F. Levi-Schaffer,et al. Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17 , 2015, British journal of pharmacology.
[215] H. Hirai,et al. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[216] S. Abraham,et al. Involvement of cellular caveolae in bacterial entry into mast cells. , 2000, Science.
[217] W. Busse,et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. , 2008, American journal of respiratory and critical care medicine.
[218] K. Waku,et al. 2‐Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL‐1 human eosinophilic leukemia cells and human peripheral blood eosinophils , 2004, Journal of leukocyte biology.
[219] P. Lincoln,et al. Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses , 2004, Clinical and experimental immunology.
[220] S. O’Neill,et al. Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis , 2015, Immunity, inflammation and disease.
[221] E. Blood,et al. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. , 2013, The Journal of allergy and clinical immunology.
[222] C. M. Davenport,et al. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. , 2001, Molecular pharmacology.
[223] R. Ward,et al. Detection of a Soluble Form of the Leukocyte Surface Antigen CD48 in Plasma and Its Elevation in Patients with Lymphoid Leukemias and Arthritis , 2004, Journal of Clinical Immunology.
[224] F. Levi-Schaffer,et al. Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation. , 2014, The Journal of investigative dermatology.
[225] L. Xue,et al. Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2). , 2007, Biochemical pharmacology.
[226] Young Hyo Kim,et al. Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective , 2015, International neurourology journal.
[227] C. Bizer,et al. Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases1 , 2002, The Journal of Immunology.
[228] C. Newton,et al. Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up-regulation of Serum IgE Levels in Immunized Mice , 2012, Journal of Neuroimmune Pharmacology.
[229] M. Manns,et al. IL-4-Induced Priming of Human Intestinal Mast Cells for Enhanced Survival and Th2 Cytokine Generation Is Reversible and Associated with Increased Activity of ERK1/2 and c-Fos1 , 2005, The Journal of Immunology.
[230] T. Betsuyaku,et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. , 2013, The Journal of allergy and clinical immunology.
[231] N. Krug,et al. Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic Asthma , 2011, Clinical pharmacology and therapeutics.
[232] H. Ohashi,et al. A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice. , 2010, Journal of pharmacological sciences.
[233] R. Sehmi,et al. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. , 2005, The Journal of allergy and clinical immunology.
[234] K. Kabashima,et al. Roles of basophils and mast cells in cutaneous inflammation , 2016, Seminars in Immunopathology.
[235] M. Babina,et al. Human skin mast cells express H2 and H4, but not H3 receptors. , 2004, The Journal of investigative dermatology.
[236] K. Sugamura,et al. Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.
[237] Rob Leurs,et al. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors , 2015, Pharmacological Reviews.
[238] Juan Zhang,et al. Aggregation of the High Affinity IgE Receptor Results in the Tyrosine Phosphorylation of the Surface Adhesion Protein PECAM-1 (CD31)* , 1997, The Journal of Biological Chemistry.
[239] F. Levi-Schaffer,et al. The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[240] P. Bradding,et al. Mast cells in asthma – state of the art , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[241] A. Hartnell,et al. Δ12-Prostaglandin J2, a Plasma Metabolite of Prostaglandin D2, Causes Eosinophil Mobilization from the Bone Marrow and Primes Eosinophils for Chemotaxis1 , 2003, The Journal of Immunology.
[242] R. Owens,et al. The crystal structure of IgE Fc reveals an asymmetrically bent conformation , 2002, Nature Immunology.
[243] A. Keane-Myers,et al. Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation , 2007, Journal of leukocyte biology.
[244] Susan M. Schlenner,et al. Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation* , 2013, The Journal of Biological Chemistry.
[245] F. Levi-Schaffer,et al. Are we ready to downregulate mast cells? , 2009, Current opinion in immunology.
[246] R. Hills,et al. CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia , 2011, Leukemia.
[247] A. Capron,et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.
[248] M. DeFelice,et al. The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review , 2016, Clinical Reviews in Allergy & Immunology.
[249] F. Di Virgilio,et al. Sphingosine 1‐phosphate induces Chemotaxis of immature dendritic cells and modulates cytokine‐release in mature human dendritic cells for emergence of Th2 immune responses , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[250] Z. Jabbar-Lopez,et al. Omalizumab, an Anti-IgE mAb, receives approval for the treatment of chronic idiopathic/spontaneous urticaria. , 2015, The Journal of investigative dermatology.
[251] F. Simons,et al. 94 – Histamine and H1 Antihistamines , 2014 .
[252] Teruaki Kimura,et al. The Protein-tyrosine Phosphatase SHP-2 Associates with Tyrosine-phosphorylated Adhesion Molecule PECAM-1 (CD31)* , 1997, The Journal of Biological Chemistry.
[253] B. Schölkens,et al. Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma. , 1996, Immunopharmacology.
[254] M. Arock,et al. Differentiation of human basophils: an overview of recent advances and pending questions , 2002, Journal of leukocyte biology.
[255] K. Wareham,et al. P2X7 receptors induce degranulation in human mast cells , 2016, Purinergic Signalling.
[256] N. Saini,et al. Lipid rafts in immune signalling: current progress and future perspective , 2016, Immunology.
[257] F. Levi-Schaffer,et al. Eosinophils interaction with mast cells: the allergic effector unit. , 2014, Methods in molecular biology.
[258] S. Durham,et al. Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. , 1997, American journal of respiratory and critical care medicine.
[259] Q. Hamid,et al. Human neutrophils express the high-affinity receptor for immunoglobulin E (FcεRI): role in asthma , 2001 .
[260] K. Ishikawa,et al. Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3. , 2016, Allergology international : official journal of the Japanese Society of Allergology.
[261] P. Howarth,et al. A new look at the pathogenesis of asthma , 2009, Clinical science.
[262] P. O'Byrne,et al. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. , 2015, The Lancet. Respiratory medicine.
[263] X. Ju,et al. Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression , 2007, Journal of leukocyte biology.
[264] I. Bachelet,et al. Suppression of Normal and Malignant Kit Signaling by a Bispecific Antibody Linking Kit with CD300a1 , 2008, The Journal of Immunology.
[265] R. Pettipher. The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responses , 2008, British journal of pharmacology.
[266] F. Levi-Schaffer,et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro , 2011, Allergy.
[267] A. Beavil,et al. Synthesis and incorporation into cyclic peptides of tolan amino acids and their hydrogenated congeners: construction of an array of A-B-loop mimetics of the Cε3 domain of human IgE. , 2012, The Journal of organic chemistry.
[268] F. Levi-Schaffer,et al. Tumor necrosis factors in a murine model of allergic peritonitis: effects on eosinophil accumulation and inflammatory mediators' release. , 2003, Cytokine.
[269] E. Fiebiger,et al. A Soluble Form of the High Affinity IgE Receptor, Fc-Epsilon-RI, Circulates in Human Serum , 2011, PloS one.
[270] H. Grubek-Jaworska,et al. [Role of eotaxin in the pathophysiology of asthma]. , 2007, Pneumonologia i alergologia polska.
[271] H. Ortega,et al. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. , 2013, Annals of the American Thoracic Society.
[272] C. Ganellin,et al. Histamine and its receptors , 2006, British journal of pharmacology.
[273] D. Cosman,et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[274] F. Borrego. The CD300 molecules: an emerging family of regulators of the immune system. , 2013, Blood.
[275] J. Phillips,et al. Molecular Mechanisms of CD200 Inhibition of Mast Cell Activation , 2004, The Journal of Immunology.
[276] L. Meyaard. The inhibitory collagen receptor LAIR‐1 (CD305) , 2008, Journal of leukocyte biology.
[277] S. Abraham,et al. Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis. , 2001, FEMS microbiology letters.
[278] K. Yasui,et al. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. , 2001, The Journal of pharmacology and experimental therapeutics.
[279] J. Ceuppens,et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients , 2006, Thorax.
[280] N. D'Ambrosi,et al. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters , 2009, The FEBS journal.
[281] D. Friend,et al. gp49B1 suppresses stem cell factor‐induced mast cell activation‐secretion and attendant inflammation in vivo , 2003, European journal of immunology.
[282] S. Nakae,et al. IL-33 and IL-33 receptors in host defense and diseases. , 2010, Allergology international : official journal of the Japanese Society of Allergology.
[283] Yusuke Suzuki,et al. Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.
[284] C. Brightling,et al. Mast cell-airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin. , 2012, Chest.
[285] W. Guan,et al. Functional Fcgamma Receptor Polymorphisms Are Associated with Human Allergy , 2014, PloS one.
[286] J. Linden,et al. Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.
[287] S. Stafford,et al. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation. , 1999, Journal of immunology.
[288] F. Liu,et al. MicroRNA-223 promotes mast cell apoptosis by targeting the insulin-like growth factor 1 receptor , 2016, Experimental and therapeutic medicine.
[289] N. Thomson. Addressing corticosteroid insensitivity in adults with asthma , 2016, Expert review of respiratory medicine.
[290] D. F. Barber,et al. Coexpression of CD58 or CD48 with Intercellular Adhesion Molecule 1 on Target Cells Enhances Adhesion of Resting NK Cells , 2003, The Journal of Immunology.
[291] Paige Lacy,et al. Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity , 2014, Front. Immunol..
[292] B. Bochner. Siglec‐8 on human eosinophils and mast cells, and Siglec‐F on murine eosinophils, are functionally related inhibitory receptors , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[293] R. Townley,et al. CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[294] M. Schubert-Zsilavecz,et al. Novel prostaglandin receptor modulators: a patent review (2002 – 2012) – part I: non-EP receptor modulators , 2013, Expert opinion on therapeutic patents.
[295] Sheng-hua Wu,et al. Efficacy and safety of 15(R/S)‐methyl‐lipoxin A4 in topical treatment of infantile eczema , 2013, The British journal of dermatology.
[296] James J. Lee,et al. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[297] D. Metcalf,et al. Stem Cell Factor Can Stimulate the Formation of Eosinophils by Two Types of Murine Eosinophil Progenitor Cells , 2002, Stem cells.
[298] J. Paulson,et al. Multivalent ligands for siglecs. , 2010, Methods in enzymology.
[299] T. Sugiura,et al. Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice1 , 2006, The Journal of Immunology.
[300] P. Crocker,et al. Siglec‐F antibody administration to mice selectively reduces blood and tissue eosinophils , 2008, Allergy.
[301] C. Ferland,et al. Mechanisms of human eosinophil migration induced by the combination of IL-5 and the endocannabinoid 2-arachidonoyl-glycerol. , 2014, The Journal of allergy and clinical immunology.
[302] R. Geha,et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.
[303] P. Kuna,et al. Eotaxin but not MCP−3 induces eosinophil influx into nasal fluid in allergic patients , 2002, Allergy.
[304] N. Hirasawa,et al. The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study. , 2014, Allergology international : official journal of the Japanese Society of Allergology.
[305] B. Kirby,et al. The role of corticotropin‐releasing hormone in immune‐mediated cutaneous inflammatory disease , 2006, Experimental dermatology.
[306] P. Neven,et al. Abstract OT2-6-04: Dovitinib, a receptor tyrosine kinase inhibitor in combination with fulvestrant in postmenopausal endocrine resistant human epidermal growth factor receptor 2 negative (HER2-) / hormone receptor-positive (HR+) breast cancer: A phase II, randomized, double blind, placebo-controlled , 2013 .
[307] C. Zhang,et al. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors , 2015, Cell cycle.
[308] T. Moon,et al. Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved , 2014, Front. Immunol..
[309] H. Rosen,et al. Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs , 2011, Molecular Pharmacology.
[310] J. Kinet,et al. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα , 2000, Nature.
[311] A. August,et al. The role of eosinophils in allergic airway inflammation. , 2010, Discovery medicine.
[312] K. Takatsu,et al. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. , 2009, International immunology.
[313] M. Diamond,et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. , 2001, Blood.
[314] Autobiography of Gertrude B. Elion, the Nobel Prize in Physiology or Medicine 1988. , 2006, The oncologist.
[315] Ajit Varki,et al. Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.
[316] J. Wood,et al. Mast Cell: A Multi-Functional Master Cell , 2016, Front. Immunol..
[317] Qutayba Hamid,et al. Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.
[318] Takeshi Watanabe,et al. Augmentation of Antigen Receptor–mediated Responses by Histamine H1 Receptor Signaling , 1999, The Journal of experimental medicine.
[319] C. Akin,et al. Tyrosine kinase inhibitors in the treatment of systemic mastocytosis. , 2011, Leukemia research.
[320] Yoshiya Tanaka,et al. Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils to Endothelial Cells , 1999 .
[321] F. Di Virgilio,et al. Functional characterization of P2Y and P2X receptors in human eosinophils , 2001, Journal of cellular physiology.
[322] J. Marcu,et al. Cannabinoid receptors: nomenclature and pharmacological principles , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[323] A. Desmoulière,et al. The Myofibroblast: one function, multiple origins , 2010 .
[324] R. Morita,et al. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren’s syndrome , 2016, Arthritis Research & Therapy.
[325] F. Levi-Schaffer,et al. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. , 2002, Molecular immunology.
[326] F. Levi-Schaffer,et al. Eosinophils as a pharmacological target for the treatment of allergic diseases. , 2014, Current opinion in pharmacology.
[327] J. Kinet,et al. Signalling through the high-affinity IgE receptor Fc epsilonRI. , 1999, Nature.
[328] J. Desjarlais,et al. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody. , 2012, The Journal of allergy and clinical immunology.
[329] F. Liew,et al. IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation , 2010, The Journal of Immunology.
[330] Marc E. Rothenberg,et al. CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils1 , 2006, The Journal of Immunology.
[331] B. Kang,et al. Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils , 2013, PloS one.
[332] J. Abramson,et al. Clustering the mast cell function-associated antigen (MAFA) leads to tyrosine phosphorylation of p62Dok and SHIP and affects RBL-2H3 cell cycle. , 2002, Immunology letters.
[333] E. Masini,et al. The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke. , 2012, Current drug targets.
[334] P. Howarth,et al. CD48 on blood leukocytes and in serum of asthma patients varies with severity , 2017, Allergy.
[335] F. Levi-Schaffer,et al. sCD48 is anti‐inflammatory in Staphylococcus aureus Enterotoxin B‐induced eosinophilic inflammation , 2016, Allergy.
[336] G. Nilsson,et al. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases , 2016, The World Allergy Organization journal.
[337] C. Serhan,et al. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. , 2012, The American journal of pathology.
[338] J. Dingemanse,et al. Clinical pharmacology, efficacy, and safety aspects of sphingosine-1-phosphate receptor modulators , 2016, Expert opinion on drug metabolism & toxicology.
[339] P. Norman. Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs , 2014, Expert opinion on investigational drugs.
[340] A. Cianferoni,et al. The importance of TSLP in allergic disease and its role as a potential therapeutic target , 2014, Expert review of clinical immunology.
[341] C. Cayrol,et al. Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members. , 2012, European cytokine network.
[342] L. M. Terán,et al. Eotaxinas en asma bronquial y poliposis nasal , 2006 .
[343] M. Idzko,et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. , 2006, The Journal of clinical investigation.
[344] G. Shi,et al. [Innate lymphoid cells and asthma]. , 2014, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[345] J. Pease,et al. Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function , 2007, Journal of leukocyte biology.
[346] M. Czerny,et al. Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodies , 2006, Allergy.
[347] J. Coligan,et al. Leukocyte-Associated Ig-like Receptor-1–Deficient Mice Have an Altered Immune Cell Phenotype , 2012, The Journal of Immunology.
[348] F. Levi-Schaffer,et al. H₄ receptors in mast cells and basophils: a new therapeutic target for allergy? , 2012, Frontiers in bioscience.
[349] W. Busse,et al. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. , 2014, The Lancet. Respiratory medicine.
[350] N. Kawasaki,et al. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. , 2012, Pharmacology & therapeutics.
[351] F. Nantel,et al. Bradykinin B1 receptor antagonist R954 inhibits eosinophil activation/proliferation/migration and increases TGF-β and VEGF in a murine model of asthma , 2010, Neuropeptides.
[352] Tao Wang,et al. Silencing of c-kit with small interference RNA attenuates inflammation in a murine model of allergic asthma. , 2012, International journal of molecular medicine.
[353] S. Jois,et al. Inhibition of cell adhesion and immune responses in the mouse model of collagen‐induced arthritis with a peptidomimetic that blocks CD2‐CD58 interface interactions , 2015, Biopolymers.
[354] C. Geczy,et al. Differential Expression of Leukocyte Immunoglobulin-like Receptors on Cord Blood-derived Human Mast Cell Progenitors and Mature Mast Cells , 2022 .
[355] L. Chiusa,et al. A Case of Intestinal Mastocytosis Misdiagnosed as Crohn's Disease , 2015, Case Reports in Gastroenterology.
[356] Alexander J Stokes,et al. Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells1 , 2003, The Journal of Immunology.
[357] P. Dubový,et al. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review , 2008, Pharmacology Biochemistry and Behavior.
[358] H. Bayes,et al. Biomarkers and asthma management: an update , 2016, Current opinion in allergy and clinical immunology.
[359] C. Hogaboam,et al. Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma , 2006, Laboratory Investigation.
[360] L. Boulet,et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. , 2014, The New England journal of medicine.
[361] A. Ray,et al. Signaling of c‐kit in dendritic cells influences adaptive immunity , 2010, Annals of the New York Academy of Sciences.
[362] G. Cabral,et al. Endocannabinoids and the Immune System in Health and Disease. , 2015, Handbook of experimental pharmacology.
[363] B. Levy,et al. Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice , 2014, Mucosal Immunology.
[364] M. Colonna,et al. A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.
[365] Michael R. Müller,et al. Detection of Novel CD Antigens on the Surface of Human Mast Cells and Basophils , 2002, International Archives of Allergy and Immunology.
[366] G. Fillion,et al. 5-HT And The Immune System , 1993 .
[367] M. Trevethick,et al. IDENTIFICATION OF A HISTAMINE H4 RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS , 2002, Journal of receptor and signal transduction research.
[368] S. Milstien,et al. Essential roles of sphingosine-1–phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema , 2010, The Journal of experimental medicine.
[369] H. Kita,et al. A critical role for vesicle‐associated membrane protein‐7 in exocytosis from human eosinophils and neutrophils , 2006, Allergy.
[370] F. Levi-Schaffer,et al. Nerve growth factor and eosinophils in inflamed juvenile conjunctival nevus. , 2002, Investigative ophthalmology & visual science.
[371] A. Olivera,et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. , 2016, European journal of pharmacology.
[372] Y. Yashiro‐Ohtani,et al. Non-CD28 Costimulatory Molecules Present in T Cell Rafts Induce T Cell Costimulation by Enhancing the Association of TCR with Rafts1 , 2000, The Journal of Immunology.
[373] V. Fainardi,et al. Mepolizumab in the treatment of severe eosinophilic asthma. , 2016, Immunotherapy.
[374] C. Lemière,et al. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. , 2016, Chest.
[375] R. Toes,et al. Mast cells in rheumatic disease. , 2016, European journal of pharmacology.
[376] P. Thompson,et al. Comparison of kinin B(1) and B(2) receptor expression in neutrophils of asthmatic and non-asthmatic subjects. , 2007, International immunopharmacology.
[377] G. Sturm,et al. Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils. , 2005, The Journal of allergy and clinical immunology.
[378] M. Tsai,et al. Mast cells and IgE in defense against venoms: Possible "good side" of allergy? , 2016, Allergology international : official journal of the Japanese Society of Allergology.
[379] A. Capron,et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. , 1991, The Journal of allergy and clinical immunology.
[380] Marcus Maurer,et al. The role of IL-33 and mast cells in allergy and inflammation , 2015, Clinical and Translational Allergy.
[381] C. Watzl,et al. WhatSAP — 2B4 sends mixed messages in the absence of SAP , 2014, European journal of immunology.
[382] C. Geest,et al. Differential expression of leukocyte‐associated Ig‐like receptor‐1 during neutrophil differentiation and activation , 2006, Journal of leukocyte biology.
[383] B. Bochner,et al. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. , 2005, Biochemical and biophysical research communications.
[384] P. Bryce,et al. IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation , 2010, PloS one.
[385] S. Bischoff. Mast cells in gastrointestinal disorders. , 2016, European journal of pharmacology.
[386] P. Weller,et al. Eosinophilia in mast cell disease. , 2014, Immunology and allergy clinics of North America.
[387] G. Sturm,et al. Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors1 , 2008, The Journal of Immunology.
[388] E. Azmitia,et al. The skin as a mirror of the soul: exploring the possible roles of serotonin , 2008, Experimental dermatology.
[389] P. A. van der Merwe,et al. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[390] B. Roth,et al. The expanded biology of serotonin. , 2009, Annual review of medicine.
[391] A. Prema,et al. Functional characterization of histamine H4 receptor on human mast cells. , 2014, Molecular immunology.
[392] Wei Zhao,et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. , 2005, The Journal of allergy and clinical immunology.
[393] F. Finkelman,et al. CD48 is critically involved in allergic eosinophilic airway inflammation. , 2007, American journal of respiratory and critical care medicine.
[394] J. Reichert. Antibodies to watch in 2016 , 2016, mAbs.
[395] L. Petecchia,et al. Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathways. , 2013, European journal of pharmacology.
[396] Min Xu,et al. Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. , 2010, The Journal of clinical investigation.
[397] A. Vannacci,et al. Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs , 2008, Journal of cellular and molecular medicine.
[398] M. Benhamou,et al. The high-affinity immunoglobulin E receptor as pharmacological target. , 2016, European journal of pharmacology.
[399] P. Amerio,et al. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. , 2003, Current drug targets. Inflammation and allergy.
[400] F. Levi-Schaffer,et al. Ultrastructural evidence for human mast cell-eosinophil interactions in vitro , 2010, Cell and Tissue Research.
[401] D. Regoli,et al. Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954 , 2014, Peptides.
[402] S. M. Monti,et al. IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site. , 2009, Molecular immunology.
[403] A. Olivera. Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. , 2008, Prostaglandins & other lipid mediators.
[404] F. Levi-Schaffer,et al. Human peripheral blood eosinophils express stem cell factor. , 2001, Blood.
[405] R. Tamagawa‐Mineoka,et al. Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis , 2013, Clinical and experimental immunology.
[406] E. Azmitia,et al. Serotonin and its 5-HT1 receptor in human mastocytosis , 2012, Immunopharmacology and immunotoxicology.
[407] P. Barnes,et al. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. , 2002, Current drug targets. Inflammation and allergy.
[408] Chunli Feng,et al. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. , 2006, Blood.
[409] J. Kinet,et al. Complete structure and expression in transfected cells of high affinity IgE receptor , 1989, Nature.
[410] Peggy H. Wong,et al. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. , 2009, The Journal of allergy and clinical immunology.
[411] T. Kitamura,et al. Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation. , 2014, The Journal of allergy and clinical immunology.
[412] J. Zisowsky,et al. A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects , 2015, Journal of clinical pharmacology.
[413] Chan Kwon Park,et al. Effect of Imatinib on Airway Smooth Muscle Thickening in a Murine Model of Chronic Asthma , 2011, International Archives of Allergy and Immunology.
[414] J. Kinet,et al. New developments in FcεRI regulation, function and inhibition , 2007, Nature Reviews Immunology.
[415] Q. Hamid,et al. Human Airway Smooth Muscle Cells Express the High Affinity Receptor for IgE (FcεRI): A Critical Role of FcεRI in Human Airway Smooth Muscle Cell Function , 2005, The Journal of Immunology.
[416] L. Zitvogel,et al. Targeting PD-1/PD-L1 interactions for cancer immunotherapy , 2012, Oncoimmunology.
[417] M. Herkenham,et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.
[418] M. McMullin,et al. Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma , 2009, Leukemia & lymphoma.
[419] Santa Jeremy Ono,et al. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis , 2012, British Journal of Ophthalmology.
[420] J. Ryan,et al. Mast cell production and response to IL-4 and IL-13. , 2015, Cytokine.
[421] K. Sung,et al. Eosinophil Tissue Recruitment to Sites of Allergic Inflammation in the Lung Is Platelet Endothelial Cell Adhesion Molecule Independent1 , 2001, The Journal of Immunology.
[422] Chang-Shin Park,et al. Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis , 2011, International neurourology journal.
[423] C. Bachert,et al. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. , 2015, The Journal of allergy and clinical immunology.
[424] D. Taub,et al. Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. , 2002, Blood.
[425] P. Nussbaumer,et al. Phosphorylation by Sphingosine Kinase 2 is Essential for in vivo Potency of FTY720 Analogues , 2008, ChemMedChem.
[426] F. Sánchez‐Madrid,et al. Sorting it out: regulation of exosome loading. , 2014, Seminars in cancer biology.
[427] H. Farkas. Icatibant as acute treatment for hereditary angioedema in adults , 2016, Expert review of clinical pharmacology.
[428] M. Löhning,et al. IL-33 in T Cell Differentiation, Function, and Immune Homeostasis. , 2016, Trends in immunology.
[429] Xueyan Fu,et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans , 2012, PloS one.
[430] T. Moon,et al. Expression of DP2 (CRTh2), a Prostaglandin D2 Receptor, in Human Mast Cells , 2014, PloS one.
[431] S. Bonini,et al. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. , 1998, The Journal of allergy and clinical immunology.
[432] D. Chi,et al. The human mast cell: an overview. , 2006, Methods in molecular biology.
[433] Hwan-You Chang,et al. Unique Epitopes on CεmX in IgE–B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells , 2010, The Journal of Immunology.
[434] M. Silkey,et al. Setipiprant, a selective CRTH2 antagonist, reduces allergen‐induced airway responses in allergic asthmatics , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[435] Steffen Jung,et al. Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development , 2013, Nature Immunology.
[436] F. Monsma,et al. Cloning and characterization of a novel human histamine receptor. , 2001, The Journal of pharmacology and experimental therapeutics.
[437] F. Levi-Schaffer,et al. Siglec-7 is an inhibitory receptor on human mast cells and basophils. , 2014, The Journal of allergy and clinical immunology.
[438] E. R. Sutherland,et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial , 2016, The Lancet.
[439] G. Walsh. Mepolizumab-based therapy in asthma: an update , 2015, Current opinion in allergy and clinical immunology.
[440] Xinzhong Dong,et al. Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions , 2014, Nature.
[441] M. Biburger,et al. FcγRIIB: a modulator of cell activation and humoral tolerance , 2012, Expert review of clinical immunology.
[442] H. Kita,et al. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. , 1996, Journal of immunology.
[443] R. Maciuca,et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies , 2015, Thorax.
[444] M. Rothenberg,et al. Targeting eosinophils in allergy, inflammation and beyond , 2013, Nature Reviews Drug Discovery.
[445] J. Reagan,et al. G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium , 2010, Pharmacology.
[446] J. Kinet,et al. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals , 1994, The Journal of experimental medicine.
[447] T. Satoh,et al. Increased expression of CRTH2 on eosinophils in allergic skin diseases , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[448] S. Wenzel. Emergence of Biomolecular Pathways to Define Novel Asthma Phenotypes. Type-2 Immunity and Beyond. , 2016, American journal of respiratory cell and molecular biology.
[449] R. Melo,et al. Eosinophil Secretion of Granule-Derived Cytokines , 2014, Front. Immunol..
[450] H. Hoffmann,et al. Human mast cells express receptors for IL‐3, IL‐5 and GM‐CSF; a partial map of receptors on human mast cells cultured in vitro , 2004, Allergy.
[451] W. Fridman,et al. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. , 1995, The Journal of clinical investigation.
[452] D. Finn,et al. Twenty‐first century mast cell stabilizers , 2013, British journal of pharmacology.
[453] H. Duffy,et al. Fibroblasts and Myofibroblasts: What Are We Talking About? , 2011, Journal of cardiovascular pharmacology.
[454] G. Bandara,et al. Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33 , 2015, European journal of immunology.
[455] B. Levy,et al. Innate immunity is a key factor for the resolution of inflammation in asthma , 2015, European Respiratory Review.
[456] F. Levi-Schaffer,et al. Mast cells and eosinophils in allergy: Close friends or just neighbors. , 2016, European journal of pharmacology.
[457] R. Kiss,et al. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update , 2014, Expert opinion on therapeutic patents.
[458] S. Durham,et al. Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. , 1998, American journal of respiratory and critical care medicine.
[459] J. Foster,et al. Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors. , 2010, The Journal of allergy and clinical immunology.
[460] N. Gray,et al. A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. , 2006, Chemistry & biology.
[461] C. Picado,et al. Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain , 2016, Clinical Drug Investigation.
[462] S. Satyanarayanajois,et al. Immunosuppression by Co‐stimulatory Molecules: Inhibition of CD2‐CD48/CD58 Interaction by Peptides from CD2 to Suppress Progression of Collagen‐induced Arthritis in Mice , 2013, Chemical biology & drug design.
[463] M. Walsh,et al. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression , 2008, The Journal of Laryngology & Otology.
[464] Megan E. McNerney,et al. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells. , 2005, Molecular immunology.
[465] S. Milstien,et al. Sphingosine-1-phosphate synthesis and functions in mast cells. , 2008, Future lipidology.
[466] Yangyang Yu,et al. Histamine H4 Receptor mediates interleukin-8 and TNF-α release in human mast cells via multiple signaling pathways. , 2016, Cellular and molecular biology.
[467] I. Iwamoto,et al. Ligation of CD31 (PECAM-1) on endothelial cells increases adhesive function of alphavbeta3 integrin and enhances beta1 integrin-mediated adhesion of eosinophils to endothelial cells. , 1999, Blood.
[468] Sarah Spiegel,et al. Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.
[469] Paige Lacy,et al. Human eosinophils express and release IL‐13 following CD28‐dependent activation , 2002, Journal of leukocyte biology.
[470] N. Akyürek,et al. Comparison of the efficacy of prednisolone, montelukast, and omalizumab in an experimental allergic rhinitis model. , 2014, Turkish journal of medical sciences.
[471] C. Wheelock,et al. Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen‐induced pulmonary inflammation in mice , 2016, Allergy.
[472] Evi Kostenis,et al. Novel CRTH2 antagonists: a review of patents from 2006 to 2009 , 2010, Expert opinion on therapeutic patents.
[473] G. Nilsson,et al. Eotaxin‐3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases , 2015, Allergy.
[474] D. Davidson,et al. The role of the purinergic P2X7 receptor in inflammation , 2007, Journal of Inflammation.
[475] U. Oh,et al. Histamine-induced itch and its relationship with pain , 2008, Molecular pain.